hydroxylamine has been researched along with bradykinin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altiok, N; Fredholm, BB | 1 |
| Lim, J; Turner, AJ | 1 |
| Beard, KM; Fantus, IG; Ho, K; Lu, H | 1 |
3 other study(ies) available for hydroxylamine and bradykinin
| Article | Year |
|---|---|
Bradykinin inhibition of cyclic AMP accumulation in D384 astrocytoma cells. Evidence against a role of cyclic GMP.
Topics: 1-Methyl-3-isobutylxanthine; Arginine; Astrocytoma; Bradykinin; Colforsin; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Humans; Hydroxylamine; Hydroxylamines; Kinetics; NG-Nitroarginine Methyl Ester; Nitroprusside; Pyrrolidinones; Rolipram; Tumor Cells, Cultured | 1992 |
Chemical modification of porcine kidney aminopeptidase P indicates the involvement of two critical histidine residues.
Topics: Aminopeptidases; Animals; Binding Sites; Bradykinin; Cell Membrane; Diethyl Pyrocarbonate; Enzyme Inhibitors; Histidine; Hydroxylamine; Hydroxylamines; Kidney; Kinetics; Oligopeptides; Peptides; Spectrophotometry, Ultraviolet; Swine | 1996 |
Bradykinin augments insulin-stimulated glucose transport in rat adipocytes via endothelial nitric oxide synthase-mediated inhibition of Jun NH2-terminal kinase.
Topics: Adipocytes; Animals; Bradykinin; Glucose; Glucose Transporter Type 4; Hydroxylamine; Insulin; Insulin Receptor Substrate Proteins; JNK Mitogen-Activated Protein Kinases; Male; Mice; Mitogen-Activated Protein Kinase 1; Nitric Oxide Synthase Type III; Phosphoproteins; Rats; Rats, Sprague-Dawley; Receptor, Bradykinin B2; Signal Transduction | 2006 |